Relapsed small cell lung cancer: treatment options and latest developments

Nomogram to predict sentinel lymph node involvement in patients with clinically node-negative breast cancer receiving neoadjuvant chemotherapy.

(2017) Lisa R. Allen et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy

(2012) Nobuhiro Asai et al.   Journal of Cancer Research and Therapeutics

A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer

(2012) Ji-Youn Han et al.   LUNG CANCER

Thymidylate synthase (TS) gene expression in primary lung cancer patients: a large-scale study in Japanese population

(2011) F. Tanaka et al.   ANNALS OF ONCOLOGY

Second-line chemotherapy for small-Cell Lung Cancer (SCLC)

(2010) Young Hak Kim et al.   CANCER TREATMENT REVIEWS

Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer

(2010) David S. Ettinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy

(2010) Robert Jotte et al.   JOURNAL OF CLINICAL ONCOLOGY

Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study

(2010) Shadia Jalal et al.   Journal of Thoracic Oncology

Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis

(2010) Ping Zhan et al.   Journal of Thoracic Oncology

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

(2009) John R. Eckardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of Small Cell Lung Carcinoma

(2009) M. Ioannou et al.   LUNG

Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients

(2009) Jun Chen et al.   LUNG CANCER

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer

(2009) Kyoichi Kaira et al.   LUNG CANCER

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

(2009) Rafael Rosell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer

(2008) A. Tatematsu et al.   CLINICAL CANCER RESEARCH

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

(2008) Jacek Jassem et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402

(2008) Akira Inoue et al.   JOURNAL OF CLINICAL ONCOLOGY

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

(2008) Athanasios G. Pallis et al.   LUNG CANCER

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

(2008) Tim Eisen et al.   LUNG CANCER

A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer

(2008) Bjørn H. Grønberg et al.   LUNG CANCER

Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients

(2008) Zeki Ustuner et al.   MEDICAL ONCOLOGY